Le Lézard
Classified in: Health, Science and technology

Healthcare Industry Leader Named Chairman of Clinical Advisory Board


WINDHAM, N.H., July 18, 2019 /PRNewswire-PRWeb/ -- Dr. Charles Safran, an internationally renowned expert in applied healthcare informatics, has been named Chairman of the Clinical Advisory Board of HydraCor, LLC. He will be advising the New Hampshire-based company on the development of new clinical applications for its AdvoCor® Platform.

"Industry leading healthcare providers increasingly recognize that it is not enough to deliver positive clinical outcomes and that they must improve the total patient experience in order to thrive in a fast-changing US healthcare system. I look forward to advising HydraCor on how to best meet this urgent need through the expansion of the AdvoCor Platform's clinical applications," said Dr Safran.

Charles Safran is a Professor of Medicine at Harvard Medical School and the former Chief of the Division of Clinical Informatics at Beth Israel Deaconess Medical Center. In 2014 he was awarded the Morris F. Collen Award, the highest honor given by the American College of Medical Informatics, for his unique contributions to the field. He has served as the President and Chairman of the American Medical Informatics Association and Vice-President of the International Medical Informatics Association. He is an elected fellow of both the American College of Physicians and the American College of Medical Informatics. Dr. Safran was also Editor-in-Chief of the International Journal of Medical Informatics for two decades. Currently, he is a council member of the Health on the Net Foundation in Geneva Switzerland and a Director of Intelligent Medical Objects, a medical terminology software company that helps clinicians capture clinical intent. He serves on the scientific advisory boards of Datavant, a San Francisco based company organizing health data, and the Multiple Myeloma Foundation.

Dr. Safran has been teaching physicians and nurses to use information and communication technology to transform healthcare for over three decades. He is the Clinical Informatics track chair for the Harvard Medical School master's program in biomedical informatics and the NLM informatics fellowship, as well as a professor with the Harvard Business School. Dr. Safran is a widely sought speaker on the future of healthcare technology, has testified before the U.S. Congress and has over 200 publications.

"We are very pleased to add Dr. Safran as an advisor, as his deep knowledge of advanced healthcare informatics will provide invaluable guidance as the Company expands the innovative applications of the AdvoCor Platform to all phases of patient care," said Ryan Sawyer, President.

HydraCor is a New Hampshire-based company and the developer of the AdvoCor Platform which uses Augmented Intelligence and statistical modeling to predict potential patient problems and help propose real-time deployment of human capital to improve patient satisfaction. AdvoCor is installed in more than 250 US hospitals across multiple service areas. For more information contact: Bob Seltzer, LockeBridge Capital Partners, 617-510-0746, bob.seltzer(at)hydracor(dot)net.

 

SOURCE HydraCor


These press releases may also interest you

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: